Kinnevik AB (publ)
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed July 8, 2024), Kinnevik AB (publ) reported 1 stock position worth $89.3 million. Its top holding was Recursion Pharmaceuticals-A (RXRX) at 100.0% of the portfolio. Compared with Q1 2024, it added to 1. The biggest buy was Recursion Pharmaceuticals-A (RXRX, shares +14%).
- Most Recent 13F
- Q3 2025
- Location
- STOCKHOLM, V7
- CIK
- 0001766574
- Portfolio Value
- $89.3M (Q2 2024)
- SEC Filing
- 0001104659-24-078298 ↗ filed Jul 8, 2024
Holdings Value
Holdings 1 stocks · $89.3M
| RXRX Recursion Pharmaceuticals-A | 100.00% | 11,905,668 | $89.3M | Add +14.4% |
Portfolio Sells Q1 2024 → Q2 2024
| None this quarter. | |||
Portfolio Buys Q1 2024 → Q2 2024
| RXRX Recursion Pharmaceuticals-A | Add +14.4% | 100.00% | 0.00 |